Raffles Medical Group’s profit drops 31% in FY2024

Revenue increased 6.3% YoY to $751.6m.

Raffles Medical Group’s profit after tax and minority interests (PATMI) declined by 31% year-on-year (YoY) to $62.2m for the financial year 2024.

The group’s revenue increased 6.3% YoY to $751.6m.

The decline in PATMI was partially attributed to lower government grants and the absence of a fair value gain from investment properties during the period.

Follow the link for more news on

Raffles Medical Group

report

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia